Trials / Completed
CompletedNCT06638372
Caffeinated Chewing Gum on Special Forces Performance
Caffeinated Chewing Gum on Special Forces Performance: a Cross-over Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- National Taiwan Sport University · Academic / Other
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to investigate the effects of caffeine chewing gum on the cognitive functions and special operations capabilities of special forces.
Detailed description
Using a randomisation crossover design, 20-40 active-duty special forces members who had undergone leave and special forces reserve training were divided into a caffeine trial (CAF) and a placebo trail (PL). After chewing caffeine-containing gum containing 5 mg/kg (CAF group) or caffeine-free gum (PL group) for 15 minutes, then performed a simple reaction test, a stroop test, a visual search test, a grip strength test, a vertical jump test, a 20-metre sprint test, and a counter-terrorism simulation test. A heart rate monitor was used to measure the heart rate and heart rate variability of the participants. Saliva samples were collected and analysed for α-Amylase, cortisol and caffeine concentrations before the test, after a 15-minute break from chewing gum and at the end of the test. Completion time of cognitive functions, grip strength, vertical jump height, 20 m sprint time, time to completion of the counterterrorism simulation test, and target score will be analysed using paired-sample t-tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | caffeine | The participants chewing either caffeine Gum (CAF trial, containing 3 mg/kg of caffeine) or Placebo Gum (PL) for 10 minutes. After rested for 15 minutes, the participants underwent tests. |
Timeline
- Start date
- 2024-10-05
- Primary completion
- 2024-10-06
- Completion
- 2025-05-30
- First posted
- 2024-10-15
- Last updated
- 2025-06-26
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06638372. Inclusion in this directory is not an endorsement.